News
Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary ...
Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary tract infections.The company has launched Methenamine Hippurate under the ...
Cipla introduces HUENA, a non-antibiotic treatment for recurrent urinary tract infections (UTIs) in India. Reduces antibiotic ...
The Malinauskas Government will bring together leaders from across the public and private sectors, unions, health experts and advocates for a ...
American Urological Association Release Recurrent Uncomplicated Urinary Tract Infections in Women Guideline Amendment Today, ...
At the early signs, try over-the-counter products such as Cystopurin or D-Mannose. Eating kefir can also help with recurrent ...
Julian Beach, MHRA Interim Executive Director, Healthcare Quality and Access, said: “As the first new type of oral antibiotic ...
The global uncomplicated urinary tract infection (UTI) treatment market is projected to grow from USD 7.7 billion in 2025 to USD 11.8 billion by 2035, reflecting a 4.4% compound annual growth rate ...
Anything with a structured waistband hurt, and even underwear or leggings touching my vulva was excruciating.” ...
A new antibiotic to treat urinary tract infections (UTIs) for the first time in almost three decades has been given the green ...
GSK Plc (GSK) has received UK approval for its oral antibiotic Blujepa (gepotidacin), designed to treat uncomplicated urinary ...
8d
Stocktwits on MSNGSK Secures UK Approval For First New Oral Antibiotic In 30 Years To Treat Resistant Urinary Tract Infections
GSK has secured UK approval for Blujepa (gepotidacin), the first new type of oral antibiotic for urinary tract infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results